Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy.

Authors

null

Emanuela Palmerini

Istituto Ortopedico Rizzoli, Bologna, Italy

Emanuela Palmerini , Robin Lewis Jones , Anna Paioli , Emanuela Marchesi , Cristina Piera Meazza , Luca Coccoli , Seth Pollack , Piero Picci , Angela Tamburini , Marilena Cesari , Eric L. Staals , Stefano Ferrari

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Bone Tumors

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 10541)

DOI

10.1200/jco.2014.32.15_suppl.10541

Abstract #

10541

Poster Bd #

248

Abstract Disclosures

Similar Posters